These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10367860)

  • 1. Possible causes for the low prevalence of pediatric urolithiasis.
    Miyake O; Yoshimura K; Tsujihata M; Yoshioka T; Koide T; Takahara S; Okuyama A
    Urology; 1999 Jun; 53(6):1229-34. PubMed ID: 10367860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strong inhibition of crystal-cell attachment by pediatric urinary macromolecules: a close relationship with high urinary citrate secretion.
    Miyake O; Kakimoto K; Tsujihata M; Yoshimura K; Takahara S; Okuyama A
    Urology; 2001 Sep; 58(3):493-7. PubMed ID: 11549512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High urinary excretion level of citrate and magnesium in children: potential etiology for the reduced incidence of pediatric urolithiasis.
    Miyake O; Yoshimura K; Yoshioka T; Koide T; Okuyama A
    Urol Res; 1998; 26(3):209-13. PubMed ID: 9694604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of fibronectin content in urinary macromolecules between normal subjects and recurrent stone formers.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto K; Takahara S; Okuyama A
    Eur Urol; 2001 Oct; 40(4):458-62. PubMed ID: 11713403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seeking consistency for the role of urinary macromolecules and glycosaminoglycans in calcium oxalate crystallization processes pertaining to the risk of renal stone formation using a multi-faceted basic science approach.
    Jappie D; Rodgers A; Webber D; Danny I Gohel M
    Clin Chim Acta; 2021 Oct; 521():76-84. PubMed ID: 34197796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the possible role of sialic acid in calcium oxalate urolithiasis.
    Yoshimura K; Yoshioka T; Miyake O; Honda M; Koide T; Okuyama A
    Eur Urol; 1998; 33(1):111-5. PubMed ID: 9471052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of proteins that inhibit calcium oxalate crystallization in vitro in the urine of normal and stone-forming individuals.
    Hedgepeth RC; Yang L; Resnick MI; Marengo SR
    Am J Kidney Dis; 2001 Jan; 37(1):104-112. PubMed ID: 11136174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K; Mayne K; Doyle IR; Ryall RL
    Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on calcium oxalate crystal formation in urolithiasis. Multi-regressive analysis of urinary CaOx crystalline volumes and the effects of urinary various substances on CaOx crystal formation].
    Kataoka K; Umekawa T; Katayama Y; Ishikawa Y; Kodama M; Takamura C; Takada M; Kato Y; Hohri K; Iguchi M
    Nihon Hinyokika Gakkai Zasshi; 1991 May; 82(5):799-803. PubMed ID: 1875573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal growth of calcium oxalate in urine of stone-formers and normal controls.
    Achilles W; Dekanić D; Burk M; Schalk C; Tucak A; Karner I
    Urol Res; 1991; 19(3):159-64. PubMed ID: 1887523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism underlying the low prevalence of pediatric calcium oxalate urolithiasis.
    Momohara C; Tsujihata M; Yoshioka I; Tsujimura A; Nonomura N; Okuyama A
    J Urol; 2009 Sep; 182(3):1201-9. PubMed ID: 19625038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of calcium oxalate crystallization by urinary macromolecules.
    Bek-Jensen H; Tiselius HG
    Urol Res; 1991; 19(3):165-9. PubMed ID: 1887524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of urinary macromolecules on the crystallization of calcium oxalate.
    Tiselius HG; Fornander AM; Nilsson MA
    Urol Res; 1990; 18(6):381-5. PubMed ID: 2100412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of the risk of calcium oxalate crystallization in urine.
    Tiselius HG
    Urol Res; 1985; 13(6):297-300. PubMed ID: 4095829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
    Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.
    Guerra A; Meschi T; Schianchi T; Allegri F; Novarini A; Borghi L
    Acta Biomed; 2002; 73(1-2):11-26. PubMed ID: 12233273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
    Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A
    Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated urine analysis in patients with calcium stone disease.
    Bek-Jensen H; Tiselius HG
    Eur Urol; 1998; 33(3):323-32. PubMed ID: 9555561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin sulfate in the stone matrix and its inhibitory effect on calcium oxalate crystallization.
    Yamaguchi S; Yoshioka T; Utsunomiya M; Koide T; Osafune M; Okuyama A; Sonoda T
    Urol Res; 1993 May; 21(3):187-92. PubMed ID: 8342253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of calcium oxalate crystal growth and aggregation by prothrombin and its fragments in vitro: relationship between protein structure and inhibitory activity.
    Grover PK; Ryall RL
    Eur J Biochem; 1999 Jul; 263(1):50-6. PubMed ID: 10429186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.